EQS-News: ABIVAX / Key word: Miscellaneous
Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
15.06.2023 / 22:41. | June 15, 2023
EQS-News: ABIVAX / Key word: Personnel
Abivax appoints Ida Hatoum as Chief People Officer
08.06.2023 / 16:20 CET/CEST
The issuer is solely responsible for the content of this. | June 8, 2023
EQS-News: ABIVAX / Key word: Miscellaneous
Abivax stock included in MSCI Indexes
08.06.2023 / 18:00 CET/CEST
The issuer is solely responsible for the content of this. | June 8, 2023
EQS-News: ABIVAX / Key word: AGM/EGM
Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
08.06.2023 / 16:21 CET/CEST
The issuer is solely. | June 8, 2023
Shareholders approved all proposed resolutions PARIS, France, June 6, 2023 - 6:00 p.m. - Abivax SA , a Phase 3 clinical-stage biotechnology. | June 6, 2023